Scotiabank Issues Positive Forecast for WELL Health Technologies (TSE:WELL) Stock Price

WELL Health Technologies (TSE:WELL) had its price target lifted by Scotiabank from C$6.00 to C$7.00 in a research report released on Monday morning,BayStreet.CA reports.

Several other brokerages have also recently issued reports on WELL. CIBC boosted their price target on WELL Health Technologies from C$5.25 to C$7.00 in a research report on Friday. Ventum Financial dropped their target price on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a report on Tuesday, October 29th. Finally, Haywood Securities upped their price target on WELL Health Technologies from C$8.00 to C$10.00 in a research note on Friday.

WELL Health Technologies Price Performance

Shares of WELL opened at C$6.99 on Monday. The firm has a fifty day moving average price of C$5.19 and a 200 day moving average price of C$4.71. The stock has a market cap of C$1.74 billion, a PE ratio of 12.26, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20. WELL Health Technologies has a 1-year low of C$3.41 and a 1-year high of C$7.05. The company has a debt-to-equity ratio of 41.57, a current ratio of 1.25 and a quick ratio of 1.02.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.